Joy M. Fulbright, MD

Hematology/Medical Oncology, Telemedicine

Joy M. Fulbright, MD

Hematology/Medical Oncology, Telemedicine

Director, Adolescent and Young Adult Program; Director, Survive and Thrive Program; Associate Professor of Pediatrics University of Missouri Kansas City School of Medicine

4.7

Rated out of 68 reviews

Headshot of Joy M. Fulbright, MD

Director, Adolescent and Young Adult Program; Director, Survive and Thrive Program; Associate Professor of Pediatrics University of Missouri Kansas City School of Medicine

4.7

Rated out of 68 reviews

For admissions, consults, and transports.

Areas of Interest

Hematology/Medical Oncology, Telemedicine
Clinical Treatment of Adolescents and Young Adults (AYA) with Cancer, Clinical Treatment of Bone Sarcomas, Research of Late Effects of Cancer Therapy

Education and Training

Degree

MD, University of Missouri-Columbia School of Medicine

Residency

Internal Medicine/Pediatrics, Good Samaritan Hospital

Fellowship

Pediatric Hematology/Oncology, M.D. Anderson Cancer Center - University of Texas

Certifications

Internal Medicine

Pediatrics

Practicing Locations

Children's Mercy Adele Hall - Hematology, Oncology, and BMT
2401 Gillham Rd Kansas City, MO 64108
View Location
Children's Mercy Joplin
3333 McIntosh Circle, Suite 6 Joplin, MO 64804
View Location

Scholarly Work

  • Select Publications
  • Generic placeholder image
    Developing a Coordinated Approach to Care for Childhood Cancer Survivors - Webinar

    Adolescent and adult survivors of childhood cancers are at increased risk for numerous physical, emotional, psychological, social and financial late effects of cancer treatment. The need for long-term follow-up care has been well established and guidelines now exist to help providers monitor for late effects. However, there continues to be a knowledge gap among health care providers related to monitoring and early diagnosis of late effects of cancer treatment. To address the knowledge gap among health care providers, Children’s Mercy Kansas City and the Midwest Cancer Alliance have de